Luo J - Search Results

1

Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker.

Zhang ZS, Huang YZ, Luo J, Wang BF, Jin Z, Liu YH, Tang YZ. Zhang ZS, et al. Among authors: luo j. Med Chem. 2018;14(6):585-594. doi: 10.2174/1573406414666180416131737. Med Chem. 2018. PMID: 29663895

2

Design, synthesis, and structure-activity relationship studies of novel pleuromutilin derivatives having a piperazine ring.

Luo J, Yang QE, Yang YY, Tang YZ, Liu YH. Luo J, et al. Chem Biol Drug Des. 2016 Nov;88(5):699-709. doi: 10.1111/cbdd.12799. Epub 2016 Jul 9. Chem Biol Drug Des. 2016. PMID: 27273921

3

Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker.

Gao ML, Zeng J, Fang X, Luo J, Jin Z, Liu YH, Tang YZ. Gao ML, et al. Among authors: luo j. Eur J Med Chem. 2017 Feb 15;127:286-295. doi: 10.1016/j.ejmech.2017.01.004. Epub 2017 Jan 3. Eur J Med Chem. 2017. PMID: 28068600

4

Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety.

Zhang ZS, Huang YZ, Luo J, Jin Z, Liu YH, Tang YZ. Zhang ZS, et al. Among authors: luo j. Chem Biol Drug Des. 2018 Sep;92(3):1627-1637. doi: 10.1111/cbdd.13328. Epub 2018 May 31. Chem Biol Drug Des. 2018. PMID: 29722184

5

Polyvalent effect enhances diglycosidic antiplasmodial activity.

Zhang WQ, He Y, Yu Q, Liu HP, Wang DM, Li XB, Luo J, Meng X, Qin HJ, Lucchi NW, Udhayakumar V, Iyer SS, Yang Y, Yu P. Zhang WQ, et al. Among authors: luo j. Eur J Med Chem. 2016 Oct 4;121:640-648. doi: 10.1016/j.ejmech.2016.05.069. Epub 2016 Jun 2. Eur J Med Chem. 2016. PMID: 27318984

6

Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents.

Zhao Z, Liu J, Yuan L, Yang Z, Kuang P, Liao H, Luo J, Feng H, Zheng F, Chen Y, Wu T, Guo J, Cao Y, Yang Y, Lin C, Zhang Q, Chen J, Pang J. Zhao Z, et al. Among authors: luo j. Eur J Med Chem. 2022 Nov 15;242:114682. doi: 10.1016/j.ejmech.2022.114682. Epub 2022 Aug 18. Eur J Med Chem. 2022. PMID: 36001935

7

Discovery of novel verinurad analogs as dual inhibitors of URAT1 and GLUT9 with improved Druggability for the treatment of hyperuricemia.

Zhao Z, Liu J, Kuang P, Luo J, Surineni G, Cen X, Wu T, Cao Y, Zhou P, Pang J, Zhang Q, Chen J. Zhao Z, et al. Among authors: luo j. Eur J Med Chem. 2022 Feb 5;229:114092. doi: 10.1016/j.ejmech.2021.114092. Epub 2021 Dec 30. Eur J Med Chem. 2022. PMID: 34998055

8

Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway.

Li L, Zhao K, Luo J, Tian J, Zheng F, Lin X, Xie Z, Jiang H, Li Y, Zhao Z, Wu T, Pang J. Li L, et al. Among authors: luo j. J Agric Food Chem. 2024 Mar 27;72(12):6565-6574. doi: 10.1021/acs.jafc.3c07655. Epub 2024 Mar 18. J Agric Food Chem. 2024. PMID: 38498316

9

Resveratrol, a novel inhibitor of GLUT9, ameliorates liver and kidney injuries in a D-galactose-induced ageing mouse model via the regulation of uric acid metabolism.

Li L, Li Y, Luo J, Jiang Y, Zhao Z, Chen Y, Huang Q, Zhang L, Wu T, Pang J. Li L, et al. Among authors: luo j. Food Funct. 2021 Sep 20;12(18):8274-8287. doi: 10.1039/d1fo00538c. Food Funct. 2021. PMID: 34180933

10

Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.

Li Y, Zhao Z, Luo J, Jiang Y, Li L, Chen Y, Zhang L, Huang Q, Cao Y, Zhou P, Wu T, Pang J. Li Y, et al. Among authors: luo j. Phytomedicine. 2021 Jul;87:153585. doi: 10.1016/j.phymed.2021.153585. Epub 2021 May 24. Phytomedicine. 2021. PMID: 34044255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,384 results

Search Page